Global Prevalence of Depressive and Anxiety Symptoms in Children and Adolescents During COVID-19

Importance: Emerging research suggests that the global prevalence of child and adolescent mental illness has increased considerably during COVID-19. These pooled estimates, which increased over time, are double of prepandemic estimates.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 However, substantial variability in prevalence rates have been reported across the literature.
• 2 Objective: To ascertain more precise estimates of the global prevalence of child and adolescent clinically elevated depression and anxiety symptoms during COVID-19; to compare these rates with prepandemic estimates; and to examine whether demographic (eg, age, sex), geographical (ie, global region), or methodological (eg, pandemic data collection time point, informant of mental illness, study quality) factors explained variation in prevalence rates across studies.
• 3 Data Sources: Four databases were searched (PsycInfo, Embase, MEDLINE, and Cochrane Central Register of Controlled Trials) from January 1, 2020, to February 16, 2021, and unpublished studies were searched in PsycArXiv on March 8, 2021, for studies reporting on child/adolescent depression and anxiety symptoms.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: